{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:37:53Z","timestamp":1756384673794},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1706","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>Pharmacologic treatment is recommended for postmenopausal women who have bone density T-scores (standard deviations from normal mean values in the spine, femoral neck, total hip, or distal radius) of -2.5 or below, T-scores between -1.0 and -2.5 with a history of fragility (low-trauma) fracture of the hip or spine, or T-scores between -1.0 and -2.5 with a FRAX 10-year probability of \u22653% for hip fracture or \u226520% for major osteoporotic fracture.<\/jats:p>","DOI":"10.58347\/tml.2024.1706a","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:11:51Z","timestamp":1723734711000},"page":"105-112","source":"Crossref","is-referenced-by-count":1,"title":["Drugs for Postmenopausal Osteoporosis"],"prefix":"10.58347","volume":"66","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2024,7,8]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:12:04Z","timestamp":1723734724000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1706a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":0,"journal-issue":{"issue":"1706","published-online":{"date-parts":[[2024,7,8]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2024.1706a","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]}}}